Nuclear Medicine

New alternatives for the optimization of cancer therapy

Nuclear Medicine | Using organ-specific preparations, we enable you to take the next step into the future of patient-specific cancer diagnosis and optimized cancer therapy. The formulation of the kits we offer makes the synthesis of the ready-to-use product quick and easy.

Lutetium 177 (Lu-177) chlorid

n.c.a (non carrier added) | custom vial | weekly availability

nuclear medicine Lu-177 Isotopia

Isotopia Molecular Imaging Ltd. (“Isotopia”) is a unique nuclear pharmacy established in Israel since 2006, and has become an essential supplier for the growing field of nuclear medicine in Israel.

Isotopia, founded by a highly trained group of senior professionals, experienced in all aspects of radiopharmacy operations, in collaboration with a group of Canadian investors.

Nowadays, Isotopia is taking steps for becoming a major worldwide supplier of Lu-177 to be used in the field of molecular radiotherapy.

Our aim is to supply Lu -177 according to costumers needs. By producing Lu-177 C.A and Lu-177 N.C.A, we can provide you both products according to your needs, tailor-made.

Key Advantages:

  • Continuous supply of Lu-177 C.A guaranteed due to cooperation with
    various nuclear reactors.
  • Availability- on a weekly basis all year round
  • You choose your volume (fixed concentration)
  • V Shaped for minimum material loss .
  • Each lot is tested for labeling efficiency

Ordering Process

3 simple Steps: just define

Icon Step 1 calibration day

1. The calibration day

Step 2 The requested volume

2. The requested volume

Step 3 The requested activity

3. The requested activity at calibration day

Lu-177 Isotopia
null

Get Lu 177 according to your needs

Product Specifications

3 simple Steps: just define

Radionuclide177LU Lutetium Chloride Solution
Half -life6.65 days
Decay ModeBeta decay
Chemical formLuCl3 in 0.04 HCI

Testc.a.n.c.a
AppearanceClear, colorless solutionClear, colorless solution
pH1.0 — 2.01.0 — 2.0
IdentificationGamma photons with 208 KeV and 113 KeV presentGamma photons with 208 KeV and 113 KeV present
Specific Activity
(by ICP-OES at end
of production)
>740 GBq/mg
(>20 Ci/mg)
>3,000 GBq/mg
Chemical Purity
(by ICP-OES)
Cu ≤ 1.0 μg/GBq
Fe ≤ 0.5 μg/GBq
Pb ≤ 0.5 μg/GBq
Zn ≤ 1.0 μg/GBq
Cu ≤1.0 μg/GBq
Fe ≤0.5 μg/GBq
Pb ≤0.5 μg/GBq
Zn ≤1.0 μg/GBq
176Yb≤1.0 μg/GBq
Radionuclidic
Purity
(Gamma spectrometry)
177mLu <0.07%175Yb < 0.1%
The total radioactivity due to other
radionuclidic impurities < 0.01%
The total radioactivity due to other
radionuclidic impurities < 0.01%
Radiochemical
Purity
(by iTLC)
[177Lu]lutetium(III) ion > 99%[177Lu]lutetium(III) ion > 99%
Bacterial Endotoxins35 < EU/ml35 < EU/ml
SterilityRetrospectively tested after decay